Mentions
19
Total raised: $57.3M

Investors 1

Funding Rounds 2

DateSeriesAmountInvestors
01.02.2012-$9.3M-
04.04.2011IPO$48M-

Mentions in press and media 19

DateTitleDescriptionSource
23.04.2013Tranzyme Pharma and Ocera Therapeutics Announce Merger Agree...domainvc.c...
01.02.2012GI treatments firm Tranzyme secures $9.3M in debt financingTranzyme, which completed an initial public stock offering last April, does not yet have any U.S. Fo...medcitynew...
08.11.2011BMY extends drug discovery collaboration with TranzymeThe funding in the extension will be under the same terms and conditions as under the existing partn...medcitynew...
11.10.2011Former Roche executive Abercrombie named to BioCryst boardAbercrombie, who has more than 30 years of experience in the pharmaceutical industry, takes the plac...medcitynew...
21.09.2011Former Roche executive Abercrombie named to Tranzyme’s board...Tranzyme does not yet have any commercialized drugs. The company’s lead drug candidate is Ulimorelin...medcitynew...
05.04.2011Stem cell therapy firm Aldagen withdraws plans for $80M IPOPromoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis h...medcitynew...
04.04.2011Tranzyme Pharma’s public offering raises $48M but IPO has li...Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Healt...medcitynew...
01.04.2011Tranzyme IPO targeted for April 4; offering re-priced at $4 ...The company likely had to lower its price to attract more buyers for stock in a company with no appr...medcitynew...
09.03.2011NC’s next IPO? Tranzyme prices offering that could raise $65...Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently...medcitynew...
27.07.2010CED NAMES 25 NORTH CAROLINA COMPANIES TO WATCHResearch Triangle Park, NC - July 27, 2010406venture...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In